Centene/$CNC
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Centene
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Ticker
$CNC
Sector
Primary listing
NYSE
Employees
60,500
Headquarters
Website
Centene Metrics
BasicAdvanced
$17B
8.45
$4.07
0.44
-
Price and volume
Market cap
$17B
Beta
0.44
52-week high
$66.81
52-week low
$25.08
Average daily volume
11M
Financial strength
Current ratio
1.098
Quick ratio
1.054
Long term debt to equity
63.818
Total debt to equity
63.909
Interest coverage (TTM)
5.10%
Profitability
EBITDA (TTM)
4,765
Gross margin (TTM)
12.75%
Net profit margin (TTM)
1.29%
Operating margin (TTM)
2.20%
Effective tax rate (TTM)
25.83%
Revenue per employee (TTM)
$2,640,000
Management effectiveness
Return on assets (TTM)
2.59%
Return on equity (TTM)
7.44%
Valuation
Price to earnings (TTM)
8.447
Price to revenue (TTM)
0.108
Price to book
0.62
Price to tangible book (TTM)
3.49
Price to free cash flow (TTM)
16.004
Free cash flow yield (TTM)
6.25%
Free cash flow per share (TTM)
2.147
Growth
Revenue change (TTM)
10.73%
Earnings per share change (TTM)
-22.58%
3-year revenue growth (CAGR)
7.31%
10-year revenue growth (CAGR)
24.02%
3-year earnings per share growth (CAGR)
8.90%
10-year earnings per share growth (CAGR)
11.31%
What the Analysts think about Centene
Analyst ratings (Buy, Hold, Sell) for Centene stock.
Bulls say / Bears say
Centene posted a surprise adjusted loss of $0.16 per share for the second quarter of 2025, far below analysts’ expectations of a profit of $0.86, sending shares down nearly 13% in premarket trading and underscoring volatility in its core results (Reuters).
The second-quarter 2025 medical cost ratio jumped to 93%, significantly above the expected 89.3%, as lower risk adjustment revenues and higher spending in Medicaid—especially for behavioral health and home health—put continued pressure on margins in government-sponsored plans (Reuters).
After posting a Q2 loss, Centene withdrew its 2025 full-year earnings forecast and now expects around $1.75 in adjusted profit per share, compared to prior guidance of more than $7.25 and analyst estimates of $4.65, highlighting management’s uncertainty about near-term earnings visibility (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.
Centene Financial Performance
Revenues and expenses
Centene Earnings Performance
Company profitability
Centene News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Centene stock?
Centene (CNC) has a market cap of $17B as of October 24, 2025.
What is the P/E ratio for Centene stock?
The price to earnings (P/E) ratio for Centene (CNC) stock is 8.45 as of October 24, 2025.
Does Centene stock pay dividends?
No, Centene (CNC) stock does not pay dividends to its shareholders as of October 24, 2025.
When is the next Centene dividend payment date?
Centene (CNC) stock does not pay dividends to its shareholders.
What is the beta indicator for Centene?
Centene (CNC) has a beta rating of 0.44. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.